- Home
- CALC vs BRLT Comparison
CALC vs BRLT Comparison
Compare CALC & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- BRLT
- Stock Information
- Founded
- CALC 2011
- BRLT 2005
- Country
- CALC United States
- BRLT United States
- Employees
- CALC N/A
- BRLT N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- BRLT Consumer Specialties
- Sector
- CALC Health Care
- BRLT Consumer Discretionary
- Exchange
- CALC Nasdaq
- BRLT Nasdaq
- Market Cap
- CALC 48.1M
- BRLT 19.8M
- IPO Year
- CALC N/A
- BRLT 2021
- Fundamental
- Price
- CALC $3.12
- BRLT $2.38
- Analyst Decision
- CALC Strong Buy
- BRLT Hold
- Analyst Count
- CALC 2
- BRLT 2
- Target Price
- CALC $14.50
- BRLT $1.80
- AVG Volume (30 Days)
- CALC 72.1K
- BRLT 292.5K
- Earning Date
- CALC 11-12-2025
- BRLT 11-06-2025
- Dividend Yield
- CALC N/A
- BRLT 10.46%
- EPS Growth
- CALC N/A
- BRLT N/A
- EPS
- CALC N/A
- BRLT N/A
- Revenue
- CALC N/A
- BRLT $422,218,000.00
- Revenue This Year
- CALC N/A
- BRLT $5.55
- Revenue Next Year
- CALC N/A
- BRLT $3.88
- P/E Ratio
- CALC N/A
- BRLT N/A
- Revenue Growth
- CALC N/A
- BRLT N/A
- 52 Week Low
- CALC $1.42
- BRLT $1.25
- 52 Week High
- CALC $5.65
- BRLT $3.10
- Technical
- Relative Strength Index (RSI)
- CALC 52.23
- BRLT 49.93
- Support Level
- CALC $2.62
- BRLT $2.33
- Resistance Level
- CALC $3.73
- BRLT $2.70
- Average True Range (ATR)
- CALC 0.36
- BRLT 0.24
- MACD
- CALC -0.01
- BRLT -0.08
- Stochastic Oscillator
- CALC 44.59
- BRLT 6.49
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.